EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Coping with checkpoint inhibitor adverse events: Assisting cancer patients in skills development - insights from the Immuno’Act© pre-experimental pilot study

Sylvie Streel, Delphine Kirkove, Rémi Gagnayre, Andrée Rorive, Pierre Freres, Christine Gennigens, Sabrina Uccello, Vanina Evrard, Véronica Greco, Irène Campos Corral, Laurence Seidel, Anne Sibille und 3 weitere

Patient Education and Counseling · 2026

DOI: 10.1016/j.pec.2026.109537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Patient Education and Counseling, 2026. Verfasst von Sylvie Streel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Hospital of Liège (CHU Liège), Liège, Belgium. Electronic address: Sylvie.Streel@chuliege.be. Hauptthemen laut MEDLINE: Neoplasms, Patient Education as Topic, Immune Checkpoint Inhibitors, Adaptation, Psychological. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPatient Education as TopicImmune Checkpoint InhibitorsAdaptation, PsychologicalSelf EfficacyDrug-Related Side Effects and Adverse ReactionsHumansFemaleMalePilot ProjectsMiddle AgedAgedDecision MakingSurveys and QuestionnairesCoping SkillsAdult

Stichwörter der Autor:innen

Coping skillsDecision makingImmune checkpoint inhibitorsImmune-related adverse eventsNeoplasmsSelf efficacyTherapeutic patient education

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical Oncology, University Hospital of Liège (CHU Liège), Liège, Belgium. Electronic address: Sylvie.Streel@chuliege.be.
  • Department of Public Health, University of Liège (ULiège), Liège, Belgium; Lab. Education and Health Promotion, University Sorbonne Paris Nord, Villetaneuse, France.
  • Lab. Education and Health Promotion, University Sorbonne Paris Nord, Villetaneuse, France.
  • Department of Medical Oncology, University Hospital of Liège (CHU Liège), Liège, Belgium.
  • Department of Nursing, University Hospital of Liège (CHU Liège), Liège, Belgium.
  • Biostatistics and Research Methods Center, University of Liège (ULiège) and University Hospital of Liège (CHU Liège), Liège, Belgium.

Förderung

  • Fondation contre le Cancer

Zitieren

APA

Streel, S., Kirkove, D., Gagnayre, R., Rorive, A., Freres, P., Gennigens, C., Uccello, S., Evrard, V., Greco, V., Campos Corral, I., Seidel, L., Sibille, A., Paulus, A., Petre, B., & Jerusalem, G. (2026). Coping with checkpoint inhibitor adverse events: Assisting cancer patients in skills development - insights from the Immuno’Act© pre-experimental pilot study. Patient Education and Counseling. https://doi.org/10.1016/j.pec.2026.109537

Vancouver

Streel S, Kirkove D, Gagnayre R, Rorive A, Freres P, Gennigens C, et al. Coping with checkpoint inhibitor adverse events: Assisting cancer patients in skills development - insights from the Immuno’Act© pre-experimental pilot study. Patient Education and Counseling. 2026. doi:10.1016/j.pec.2026.109537

BibTeX
@article{Streel2026,
  author = {Streel, Sylvie and Kirkove, Delphine and Gagnayre, Rémi and Rorive, Andrée and Freres, Pierre and Gennigens, Christine and Uccello, Sabrina and Evrard, Vanina and Greco, Véronica and Campos Corral, Irène and Seidel, Laurence and Sibille, Anne and Paulus, Astrid and Petre, Benoit and Jerusalem, Guy},
  title = {Coping with checkpoint inhibitor adverse events: Assisting cancer patients in skills development - insights from the Immuno’Act© pre-experimental pilot study},
  journal = {Patient Education and Counseling},
  year = {2026},
  doi = {10.1016/j.pec.2026.109537}
}
Kostenlos starten →